Axicabtagene Ciloleucel Expanded Access Study

Clinical trial NCT03153462 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT03153462
Sponsor: Kite, A Gilead Company
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Relapsed/Refractory Diffuse Large B Cell Lymphoma Relapsed/Refractory Primary Mediastinal B Cell Lymphoma Relapsed/Refractory Transformed Follicular Lymphoma Relapsed/Refractory High-Grade B-Cell Lymphoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.